This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
by Zacks Equity Research
ISRG secures FDA clearance for the first stapler designed for single-port robotic surgery, advancing minimally invasive procedures and enhancing surgical precision.
ANGONegative Net Change ISRGNegative Net Change MASIPositive Net Change VEEVPositive Net Change
medical medical-devices
Bruker Stock May Benefit Following Its Investment in Ridom GmbH
by Zacks Equity Research
BRKR announces a new partnership with NGS bioinformatics solution provider Ridom GmbH.
ABTPositive Net Change PODDPositive Net Change BRKRNegative Net Change VCYTNo Net Change
medical medical-devices
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?
by Urmimala Biswas
Both TEM and DOCS are technology-intensive healthcare companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment? Let's see.
DOCSNegative Net Change TEMNegative Net Change
artificial-intelligence computers healthcare iot medical medical-devices smart-health
DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance
by Zacks Equity Research
DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding diabetes care access.
ANGONegative Net Change MASIPositive Net Change DXCMNegative Net Change VEEVPositive Net Change
medical medical-devices
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL continues to gain from its robust product portfolio and strong segmental performance.
ECLPositive Net Change ANGONegative Net Change MASIPositive Net Change VEEVPositive Net Change
medical medical-devices
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
by Zacks Equity Research
BRKR's latest innovation offers 1H NMR and a choice of 15 X-nuclei with just one click.
ABTPositive Net Change PODDPositive Net Change BRKRNegative Net Change VCYTNo Net Change
medical medical-devices
Top Research Reports for Eli Lilly, American Express & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American Express Company (AXP) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks, Steel Partners Holdings L.P. (SPLP) and Oil-Dri Corporation of America (ODC).
LLYPositive Net Change AXPNegative Net Change TMONegative Net Change
fin-tech medical-devices pharmaceuticals
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025
by Urmimala Biswas
AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.
HCATNegative Net Change BFLYNegative Net Change TEMNegative Net Change
artificial-intelligence iot medical medical-devices smart-health
Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract
by Zacks Equity Research
NEOG posts lower-than-expected earnings and revenues for the third quarter of fiscal 2025.
ANGONegative Net Change MASIPositive Net Change NEOGPositive Net Change VEEVPositive Net Change
earnings medical medical-devices
Here's Why You Should Add Cencora Stock to Your Portfolio Now
by Zacks Equity Research
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
ABTPositive Net Change ALGNNegative Net Change MASIPositive Net Change CORPositive Net Change
medical medical-devices
Should You Continue to Hold NVST Stock in Your Portfolio?
by Zacks Equity Research
Investors are optimistic about Envista, thanks to its strong momentum in the Specialty Products and Technologies segment.
ABTPositive Net Change BSXPositive Net Change MASIPositive Net Change NVSTPositive Net Change
medical medical-devices
Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On
by Urmimala Biswas
Investors looking to maintain exposure to healthcare can invest in large-cap U.S.-based companies like UHS, BMRN and ABT.
ABTPositive Net Change BMRNNegative Net Change UHSPositive Net Change
biotechs medical medical-devices pharmaceuticals
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
by Zacks Equity Research
QDEL continues to witness growth on the back of its strong product portfolio.
BSXPositive Net Change ANGONegative Net Change MASIPositive Net Change QDELNegative Net Change
medical medical-devices
Telix Shares May Gain on the Distribution Deal With Cardinal Health
by Zacks Equity Research
TLX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.
ANGONegative Net Change CAHPositive Net Change MASIPositive Net Change TLXNegative Net Change
medical medical-devices
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry
by Debanjana Dey
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
DVAPositive Net Change ADUSPositive Net Change EHCPositive Net Change OPCHPositive Net Change
medical medical-devices
Is it the Right Time to Retain Labcorp Stock in Your Portfolio?
by Zacks Equity Research
LH's growth opportunities in important specialty testing areas are robust. Expanding through strategic acquisitions is an added plus.
ABTPositive Net Change BSXPositive Net Change LHPositive Net Change MASIPositive Net Change
medical medical-devices
Do Options Traders Know Something About Integra (IART) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Integra (IART) stock based on the movements in the options market lately.
IARTPositive Net Change
medical medical-devices
Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down
by Zacks Equity Research
WBA delivers better-than-expected earnings and revenues in the second quarter of fiscal 2025.
ANGONegative Net Change MASIPositive Net Change VEEVPositive Net Change WBAPositive Net Change
earnings medical medical-devices
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
by Zacks Equity Research
ICU Medical unveils a strategic plan to offset new U.S. tariffs, aiming to protect margins and stability amid medtech market volatility and global trade shifts.
ABTPositive Net Change ALGNNegative Net Change MASIPositive Net Change ICUIPositive Net Change
medical medical-devices
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
by Zacks Equity Research
ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety.
ABTPositive Net Change BSXPositive Net Change ICUIPositive Net Change CORPositive Net Change
medical medical-devices
GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform
by Zacks Equity Research
GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.
BSXPositive Net Change CAHPositive Net Change MASIPositive Net Change GDRXNegative Net Change
medical medical-devices
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up
by Zacks Equity Research
BRKR's new 1.3 GHz high-resolution NMR system comes with a stable, standard-bore 54 mm superconducting magnet.
ABTPositive Net Change BSXPositive Net Change BRKRNegative Net Change HIMSNegative Net Change
medical medical-devices
BD Seeks Potential Buyers for Life Sciences Business Division
by Zacks Equity Research
Becton Dickinson is in preliminary talks to divest its $21 billion Life Sciences unit, exploring multiple options with major medtech players and diagnostics firms.
BSXPositive Net Change BDXPositive Net Change ALGNNegative Net Change MASIPositive Net Change
medical medical-devices
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
by Zacks Equity Research
CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
BSXPositive Net Change CNMDPositive Net Change ALGNNegative Net Change MASIPositive Net Change
medical medical-devices
ZBH Stock to Gain From Volume Growth Amid Rising Costs
by Zacks Equity Research
Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.
BSXPositive Net Change CAHPositive Net Change MASIPositive Net Change ZBHPositive Net Change
medical medical-devices